Credelio For Cats (48mg) 12 Doses

What is Credelio For Cats (48mg) 12 Doses?

Credelio For Cats (48mg) 12 Doses is a veterinarian-prescribed oral medication designed to kill fleas on cats within 8 hours and provide full protection for up to 30 days per dose. Manufactured by Elanco, this FDA-approved treatment contains lotilaner, an isoxazoline-class parasiticide that targets the nervous system of fleas. Each pack contains 12 chewable tablets, each dosed at 48mg, intended for cats weighing between 4.4 and 11 pounds. It is not intended for use in kittens under 8 weeks of age or those weighing less than 2.8 lbs.

Key features

• Fast-acting formula — kills fleas within 8 hours of administration.
• Monthly protection — one tablet provides up to 30 days of flea control.
• Chewable tablet — easy to administer with food, no residue or mess.
• Prescription-based — requires vet approval for purchase and use.
• Targets adult fleas — prevents flea infestations by eliminating live fleas before they lay eggs.
• 12-dose supply — full year of treatment in one package.
• FDA-approved — backed by clinical studies and veterinary endorsement.

Who is Credelio For Cats (48mg) 12 Doses for?

This product is ideal for cat owners seeking a reliable, prescription-grade flea treatment for indoor or outdoor cats. It suits households in high-flea regions or those dealing with seasonal infestations. It’s especially beneficial for owners who prefer oral medications over topical solutions to avoid greasy residues or application site irritation. Not suitable for kittens under 8 weeks or cats with known hypersensitivity to lotilaner.

How does Credelio For Cats (48mg) 12 Doses compare?

Compared to over-the-counter topical treatments, Credelio offers faster flea kill times and eliminates concerns about transfer to humans or furniture. Unlike some monthly spot-ons that require 24–48 hours to take effect, Credelio begins working in under 8 hours. It competes directly with other prescription oral flea medications like Bravecto for Cats but differs by offering monthly rather than 12-week protection. It does not treat ticks, unlike broader-spectrum alternatives, making it best suited for flea-specific prevention.